In this short review paper, the significant and profound impacts of the distorted key theory for developing peptide drugs have been briefly recalled with crystal clear convincingness.
AIDS Peptide Drugs Distorted Key Theory MicroenvironmentCONFLICTS OF INTEREST
The author declares no conflicts of interest regarding the publication of this paper.
REFERENCESReferencesBarre-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W. and Montagnier, L. (1983) Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS). Science, 220, 868-871.
https://doi.org/10.1126/science.6189183Meek, T.D., Lambert, D.M., Dreyer, G.B., Carr, T.J., Tomaszek Jr., T.A., Moore, M.L., Strickler, J.E., Debouck, C., Hyland, L.J., Matthews, T.J., et al. (1990) Inhibition of HIV-1 Protease in Infected T-Lymphocytes by Synthetic Peptide Analogues. Nature, 343, 90-92. https://doi.org/10.1038/343090a0Chou K.C. ,et al. (1993)A Vectorized Sequence-Coupling Model for Predicting HIV Protease Cleavage Sites in Proteins The Journal of Biological Chemistry 268, 16938-16948.Miller, M., Schneider, J., Sathyanarayana, B.K., Toth, M.V., Marshall, G.R., Clawson, L., Selk, L., Kent, S.B. and Wlodawer, A. (1989) Structure of Complex of Synthetic HIV-1 Protease with a Substrate-Based Inhibitor at 2.3 A Resolution. Science, 246, 1149-1152. https://doi.org/10.1126/science.2686029Chou, K.C. (1996) Review: Prediction of Human Immunodeficiency Virus Protease Cleavage Sites in Proteins. Analytical Biochemistry, 233, 1-14. https://doi.org/10.1006/abio.1996.0001Chou, K.C., Tomasselli, A.L., Reardon, I.M. and Heinrikson, R.L. (1996) Predicting HIV Protease Cleavage Sites in Proteins by a Discriminant Function Method. Proteins: Structure, Function and Genetics, 24, 51-72.
https://doi.org/10.1002/(SICI)1097-0134(199601)24:1<51::AID-PROT4>3.0.CO;2-RChou, J.J. (1993) Predicting Cleavability of Peptide Sequences by HIV Protease via Correlation-Angle Approach. Journal of Protein Chemistry, 12, 291-302. https://doi.org/10.1007/BF01028191Liang, G.Z. and Li, S.Z. (2007) A New Sequence Representation as Applied in Better Specificity Elucidation for Human Immunodeficiency Virus Type 1 Protease. Biopolymers, 88, 401-412. https://doi.org/10.1002/bip.20669Shen, H.B. and Chou, K.C. (2008) HIVcleave: A Web-Server for Predicting HIV Protease Cleavage Sites in Proteins. Analytical Biochemistry, 375, 388-390. https://doi.org/10.1016/j.ab.2008.01.012Gan, Y.R., Huang, H., Huang, Y.D., Rao, C.M., Zhao, Y., Liu, J.S., Wu, L. and Wei, D.Q. (2006) Synthesis and Activity of an Octapeptide Inhibitor Designed for SARS Coronavirus Main Proteinase. Peptides, 27, 622-625.
https://doi.org/10.1016/j.peptides.2005.09.006Du, Q.S., Wang, S.Q., Jiang, Z.Q., Gao, W.N., Li, Y.D., Wei, D.Q. and Chou, K.C. (2005) Application of Bioinformatics in Search for Cleavable Peptides of SARS-CoV Mpro and Chemical Modification of Octapeptides. Medicinal Chemistry, 1, 209-213. https://doi.org/10.2174/1573406053765468Du, Q.S., Sun, H. and Chou, K.C. (2007) Inhibitor Design for SARS Coronavirus Main Protease Based on “Distorted Key Theory”. Medicinal Chemistry, 3, 1-6. https://doi.org/10.2174/157340607779317616